NKGen Biotech, Inc. Common Stock (NKGN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 2.38M | 24K | 911K | 1.25M | 1.61M | 1.93M | 10.35M | 75.64K | 295.17K | 350K | 1.15M | 1.8M | 2.1M | 2.54M | 2.85M | 3.12M |
| Cash & Short-Term Investments | 6K | 0 | 8K | 79K | 34K | 26K | 8.79M | 41.46K | 206.8K | 117K | 728.01K | 1.26M | 1.44M | 1.72M | 1.89M | 2.01M |
| Cash Only | 6K | 0 | 8K | 79K | 34K | 26K | 8.79M | 41.46K | 206.8K | 117K | 728.01K | 1.26M | 1.44M | 1.72M | 1.89M | 2.01M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 23K | 24K | 24K | 23K | 26K | 26K | 41K | 0 | 0 | 96K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | 13.44 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.7M | 0 | 229K | 274K | 297K | 313K | 322K | 34.18K | 88.37K | 4K | 418.57K | 537.7K | 661K | 812.72K | 952.55K | 1.11M |
| Total Non-Current Assets | 13.46M | 0 | 14.08M | 14.4M | 14.71M | 14.55M | 14.85M | 63.53M | 175.38M | 15.98M | 172.73M | 171.84M | 171.7M | 171.66M | 171.64M | 171.62M |
| Property, Plant & Equipment | 13.37M | 0 | 13.99M | 14.31M | 14.62M | 14.46M | 14.76M | 0 | 0 | 15.88M | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 96K | 0 | 93K | 93K | 91K | 92K | 90K | 0 | 0 | 97K | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63.53M | 175.38M | 0 | 172.73M | 171.82M | 171.7M | 171.66M | 171.64M | 171.62M |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.84M | 24K | 14.99M | 15.65M | 16.32M | 16.48M | 25.2M | 63.61M | 175.68M | 16.33M | 173.88M | 173.64M | 173.8M | 174.19M | 174.48M | 174.74M |
| Asset Turnover | - | 27.17x | - | - | - | - | - | - | - | - | 0.00x | - | - | - | - | - |
| Asset Growth % | -2.91% | -99.85% | -40.49% | -75.4% | -90.71% | 0.92% | -85.51% | -63.37% | 1.08% | -90.63% | -0.35% | -0.63% | - | - | - | - |
| Total Current Liabilities | 43.89M | 0 | 37.12M | 51.41M | 37.48M | 39.45M | 38.85M | 6.3M | 3.53M | 14.74M | 2.77M | 2.86M | 2.19M | 1.89M | 798.73K | 267.84K |
| Accounts Payable | 15.24M | 0 | 13.45M | 12.69M | 12.84M | 11.04M | 7.94M | 0 | 0 | 975K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | 23.73K | - | - | - | - | - | - |
| Short-Term Debt | 26.76M | 0 | 19.7M | 17.27M | 11.56M | 9.99M | 5.23M | 416.71K | 0 | 11.65M | 0 | 0 | 0 | 0 | 0 | 18.39K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.28M | 0 | 1.58M | 19.59M | 11.18M | 16.77M | 21.13M | 5.89M | 3.53M | 346K | 2.77M | 2.86M | 2.19M | 1.89M | 798.73K | 249.45K |
| Current Ratio | 0.05x | - | 0.02x | 0.02x | 0.04x | 0.05x | 0.27x | 0.01x | 0.08x | 0.02x | 0.41x | 0.63x | 0.96x | 1.34x | 3.56x | 11.65x |
| Quick Ratio | 0.05x | - | 0.02x | 0.02x | 0.04x | 0.05x | 0.27x | 0.01x | 0.08x | 0.02x | 0.41x | 0.63x | 0.96x | 1.34x | 3.56x | 11.65x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 22.29M | 0 | 24.93M | 33.96M | 33.89M | 35.72M | 26.99M | 3.05M | 2.76M | 26K | 2.81M | 3.38M | 8.89M | 11.58M | 11.63M | 17.1M |
| Long-Term Debt | 11.08M | 0 | 10.6M | 10.37M | 10.15M | 9.93M | 14.71M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 206K | 0 | 282K | 316K | 348K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 8K | 0 | 33K | 33K | 33K | 33K | 26K | 0 | 0 | 26K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 10.99M | 0 | 14.01M | 23.24M | 23.36M | 25.76M | 12.26M | 3.05M | 2.76M | 0 | 2.81M | 3.38M | 8.89M | 11.58M | 11.63M | 11.1M |
| Total Liabilities | 66.17M | 0 | 62.05M | 85.36M | 71.37M | 75.17M | 65.84M | 9.35M | 6.29M | 14.77M | 5.58M | 6.23M | 11.08M | 13.47M | 12.42M | 17.37M |
| Total Debt | 38.19M | 0 | 30.74M | 28.12M | 22.21M | 19.92M | 20.03M | 416.71K | 0 | 12.03M | 0 | 0 | 0 | 0 | 0 | 18.39K |
| Net Debt | 38.19M | 0 | 30.73M | 28.04M | 22.18M | 19.89M | 11.25M | 375.25K | -206.8K | 11.92M | -728.01K | -1.26M | -1.44M | -1.72M | -1.89M | -1.99M |
| Debt / Equity | - | - | - | - | - | - | - | 0.01x | - | 7.70x | - | - | - | - | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -9.17x | -1.04x | -14.38x | -11.53x | -7.13x | -21.53x | -32.72x | -106.63x | -199.94x | -10.16x | -9.42x | - | - | - | - | - |
| Total Equity | -50.33M | 0 | -47.05M | -69.72M | -55.05M | -58.69M | -40.64M | 54.26M | 169.38M | 1.56M | 168.29M | 167.4M | 162.72M | 160.72M | 162.06M | 157.37M |
| Equity Growth % | 8.58% | 100% | -15.78% | -228.49% | -132.5% | -3855.15% | -124.15% | -67.59% | 4.09% | -99.03% | 3.85% | 6.38% | - | - | - | - |
| Book Value per Share | -1.75 | - | -1.95 | -2.88 | -2.51 | -2.68 | -3.03 | 3.22 | 7.90 | 0.07 | 7.85 | 7.80 | 7.59 | 7.49 | 7.55 | 7.34 |
| Total Shareholders' Equity | -50.33M | 0 | -47.05M | -69.72M | -55.05M | -58.69M | -40.64M | 54.26M | 169.38M | 1.56M | 168.29M | 167.4M | 162.72M | 160.72M | 162.06M | 157.37M |
| Common Stock | 5K | 0 | 4K | 3K | 2K | 2K | 2K | 62.8M | 174.68M | 1K | 172.2M | 171.62M | 171.62M | 171.62M | 171.62M | 152.37M |
| Retained Earnings | -191.07M | 0 | -177M | -183.6M | -167.51M | -162.13M | -128.52M | -8.54M | -5.3M | -79.18M | -3.91M | -4.21M | -8.89M | -10.9M | -9.56M | -4.35M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |